ANGO : Analysis & Opinions

  1. Merit Medical Hits 52-Week High on Product Pipeline Strength ...

    December 19, 2014
    Strong third-quarter results, a string of FDA approvals for its new products along with a robust product pipeline, all contribute ...
  2. AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst ...

    December 18, 2014
    Shares of AngioDynamics Inc (ANGO) reached a 52-week high of $19.20 on Dec 17, 2014.
  3. CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst ...

    December 17, 2014
    CR Bard's initiative to introduce its products in the emerging markets is delivering accretive returns, as the company continues ...
  4. Merit Medical Wins FDA Approval for Multiple Devices - Analyst ...

    December 15, 2014
    Developer of medical devices, Merit Medical Systems, Inc. (MMSI), recently announced that the U.S. Food and Drug Administration ...
  5. ANGO Wins Twin Approval - Analyst Blog

    June 28, 2013
    AngioDynamics has won regulatory approval for two of its port offerings, which came in as a major boost to its vascular access ...
  6. AngioDynamics Still Struggling To Get Back On Track

    April 10, 2013
    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
  7. ANGO Beats on EPS, Tweaks View - Analyst Blog

    January 4, 2013
    AngioDynamics Inc. (ANGO) reported adjusted earnings of 10 cents per share for the second quarter of fiscal 2013 ended November ...
  8. AngioDynamics Wins GPO Contract - Analyst Blog

    October 11, 2012
    Therapeutic and diagnostic devices maker AngioDynamics (ANGO) recently won a contract with HealthTrust Purchasing Group, ...
Trading Center